Plasma Treated MDI Canisters

Plasma Technology from H&T Presspart

H&T Presspart has developed a revolutionary sub-micron plasma technology process for treating the internal surface of metered-dose inhaler canisters.

The H&T Presspart plasma treatment process improves the surface energy properties of an MDI canister, thus helping to prevent the active content of a drug formulation adhering to the canister wall. This ensures that the patient receives the prescribed dose and solves an inherent problem present within many of today’s metered dose inhalers.

There is also the added benefit of enhanced drug stability performance, in formulations where interactions with the aluminium substrate can lead to product degradation and reduced shelf life.

Advantages of H&T Presspart’s plasma treatment for metered dose inhaler canisters:

  • Uses ultra-pure monomers (99.99% purity).
  • No solvents or other waste products produced.
  • No resulting extractable or leachable material.
  • Canisters are cleaned during the plasma process.
  • Surface treatment fully replicates the contours of the canister.
  • Low surface energy polymerised nanolayer for high degree of repellency.
  • Scalable volume process with excellent cycle to cycle repeatability.
  • No need for post treatment baking at high temperature.

Contact us to discuss the options for plasma treatment or to learn more about H&T Presspart’s plasma technology. To see more information on our plasma process, download the information sheet.

MDI canister plasma

MDI cans

About Presspart

About Presspart Drawing on 42 years of success, Presspart Manufacturing Ltd has developed in to a World-leader of bespoke deep-drawn and injection moulded components, with manufacturing plants located across the Globe. Presspart's ability to offer customers a unique service in toolmaking, design and development skills has been the foundation for more than four decades of successful … read more

Inhalation Product Technology Centre from Presspart

Inhalation Product Technology Centre (IPTC)

Inhalation Product Technology Centre (IPTC) from Presspart Supporting the strategic projects of Presspart and our customers Here at Presspart Manufacturing, we have further expanded our research and development capabilities with the introduction of an Inhalation Product Technology Centre (IPTC). As the world’s leading manufacturer of components for metered dose inhalers, including MDI canisters … read more

Little girl inhaler iStock_000064222463_Small

Is Asthma Overdiagnosed?

Recent studies by scientists have led to claims that asthma is being too readily diagnosed, especially when it comes to children. It’s said that doctors are too quick to diagnose young children with asthma, even though a lot of the time they don’t actually have the illness. Two specialists on asthma have said that inhalers are now being dispensed like “fashion accessories.” When used properly, … read more

Connected MDI

Cohero Health and Presspart introduce their Connected MDI

Cohero Health and H&T Presspart Announce Completion of Connected Metered Dose Inhaler Multi-year collaboration yields world’s first connected inhaler for tracking and improving medication adherence Cohero Health, a digital health company focused on developing connected health tools and technologies to empower respiratory patients and improve care through smart mobile devices, and H&T … read more

© Copyright Presspart Manufacturing Ltd. All Rights Reserved | Whitebirk Ind. Est. Blackburn, Lancashire, BB1 5RF United Kingdom Tel: +44 (0)1254 582233 | Site:
Privacy Policy | Imprint